FDA Approves New HIV Drug for Adults with Limited Treatment …
https://www.hiv.gov/blog/fda-approves-new-hiv-drug-for-adults-with-limited-treatment-options
WebJan 4, 2023 · [On December 22, 2022], the U.S. Food and Drug Administration approved Sunlenca (lenacapavir), a new type of antiretroviral medication for adult patients living with human immunodeficiency virus type 1 (HIV-1), whose HIV infections cannot be successfully treated with other available treatments due to resistance, intolerance, or safety considerat...
DA: 16 PA: 96 MOZ Rank: 68